Moolec Science (MLEC) Cost of Revenue (2022 - 2024)
Moolec Science (MLEC) reported Cost of Revenue of $3.3 million for Q4 2024, up 16453.56% on a YoY basis from N/an in Q1 2024, and up 115.1% sequentially from $1.5 million in Q3 2024.
Moolec Science (MLEC) Cost of Revenue (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Cost of Revenue data on file, last reported at $3.3 million in Q4 2024.
- For the quarter ending Q4 2024, Cost of Revenue rose 16453.56% year-over-year to $3.3 million; the trailing twelve-month figure through Dec 2024 stood at $8.5 million (up 232.48% YoY), and the FY2024 full-year result was $5.2 million, up 391.49% from the prior year.
- Cost of Revenue improved to $3.3 million in Q4 2024, from $1.5 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $3.3 million in Q4 2024 to a low of $5455.0 in Q1 2022.
- A 3-year average of $923968.4 and a median of $507953.0 in 2022 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue decreased 2.11% in 2023 and surged 16453.56% in 2024, its largest moves.
- Tracing MLEC's Cost of Revenue over 3 years: stood at $20473.0 in 2022, then fell by 2.11% to $20040.0 in 2023, then surged by 16453.56% to $3.3 million in 2024.
- Business Quant data shows MLEC's Cost of Revenue at $3.3 million in Q4 2024, $1.5 million in Q3 2024, and $1.6 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 167.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 392.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 296.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.32 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | 20,040.00 |
| Dec 31, 2023 | 20,040.00 |
| Sep 30, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 994,199.00 |
| Jun 30, 2023 | 994,199.00 |
| Mar 31, 2023 | 14,364.00 |
| Mar 31, 2023 | 14,364.00 |
| Dec 31, 2022 | 20,473.00 |
| Dec 31, 2022 | 20,473.00 |
| Sep 30, 2022 | 19,318.00 |
| Sep 30, 2022 | 19,318.00 |